✦ LIBER ✦

The gastric H,K-ATPase blocker lansoprazole is an inhibitor of chloride channels

✍ Scribed by Andreas Schmarda; Patrick Dinkhauser; Martin Gschwentner; Markus Ritter; Johannes Fürst; Elke Scandella; Ewald Wöll; Andreas Laich; Heidi Rossmann; Ursula Seidler; Florian Lang; Markus Paulmichl

Book ID: 110004777
Publisher: Nature Publishing Group
Year: 2000
Tongue: English
Weight: 455 KB
Volume: 129
Category: Article
ISSN: 0007-1188
DOI: 10.1038/sj.bjp.0703070

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The effects of lansoprazole, a new H+,K+

The effects of lansoprazole, a new H+,K+-ATPase inhibitor, on gastric pH and serum gastrin

✍ S. W. SANDERS; K. G. TOLMAN; P. A. GRESKI; D. E. JENNINGS; P. A. HOYOS; J. G. PA 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 761 KB

Cibenzoline, an ATP-sensitive K+ channel

Cibenzoline, an ATP-sensitive K+ channel blocker, binds to the K+-binding site from the cytoplasmic side of gastric H+,K+-ATPase

✍ Yoshiaki Tabuchi; Hiroaki Yashiro; Satomi Hoshina; Shinji Asano; Noriaki Takeguc 📂 Article 📅 2001 🏛 Nature Publishing Group 🌐 English ⚖ 212 KB

Synthetic Studies Connected with the Pre

Synthetic Studies Connected with the Preparation of H+/K+-ATPase Inhibitors Rabeprazole and Lansoprazole.

✍ Stanislav Radl; Ondrej Klecan; Jaroslav Havlicek 📂 Article 📅 2007 🏛 John Wiley and Sons ⚖ 25 KB

Synthetic studies connected with the pre

Synthetic studies connected with the preparation of h+/k+-ATPase inhibitors rabeprazole and lansoprazole

✍ Stanislav Rédl; Ondřej Klecén; Jaroslav Havlíček 📂 Article 📅 2006 🏛 Journal of Heterocyclic Chemistry 🌐 English ⚖ 391 KB

## Abstract magnified image Synthesis of lansoprazole and rabeprazole using common intermediates is devised. The common intermediates, 2‐[(4‐nitro‐3‐methylpyridin‐2‐yl)methanesulfanyl]‐1__H__‐benzoimidazole and 2‐[(4‐chloro‐3‐methyl‐pyridin‐2‐yl)methanesulfanyl]‐1__H__‐benzoimidazole, were prepare

Gastric antisecretory activity of an aci

Gastric antisecretory activity of an acid stable H+/K+ ATPase inhibitor, WY-26,769

✍ John F. DiJoseph; George J. Palumbo; Roger Crossley; Arthur A. Santilli; Susan T 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 406 KB

Wy-26,769 (2-3-dihydro-2-(2-pyridinyl) thiazolo-[3,2-a]benzimidazole) is a gastric antisecretory agent that acts by inhibiting the parietal cell proton pump. In vitro, Wy-26,769 was active against dbcAMP-stimulated aminopyrine uptake in isolated parietal cells. Preincubating the drug with liver mic

4-(2-PYRTOYL)-5-phenylthiazoles as novel

4-(2-PYRTOYL)-5-phenylthiazoles as novel non-bicyclic reversible inhibitors of the gastric H+/K+-atpase

✍ R.J. Ife; C.A. Leach; A.J. Pope; C.J. Theobald 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 289 KB